摘要
目的:探讨介入治疗肝门部恶性梗阻性黄疸的临床疗效。方法:收集2012年7月至2013年6月郑州大学第一附属医院收治的22例肝门部恶性梗阻性黄疸患者临床资料,所有患者均接受经皮肝穿刺胆道引流(percutaneous transhepatic cholangial drainage,PTCD)治疗,比较患者治疗前后血清总胆红素的变化,评价疗效。计量资料用t检验。结果:介入治疗成功率为100%。治疗后2周血清总胆红素下降明显(P<0.05)。术后并发症7例,给予相应治疗后症状消失,无严重并发症发生。结论:PTCD术治疗肝门部恶性梗阻性黄疸可有效缓解黄疸症状,患者耐受性良好,为后续抗肿瘤治疗提供机会。
Objective: To evaluate the clinical efficacy of interventional therapy for hilar malignant obstructive jaundice. Methods: 22 patients with hilar malignant obstructive jaundice were treated by percutaneous transhepatic cholangial drainage(PTCD) in the First Affiliated Hospital ofZheng- zhou University from July 2012 to June 2013. The clinical efficacy was evaluated by comparing the preoperative and postoperative levels of bilirubin. Results: All the patients were operated success- fully. The total bilirubin levels descended obviously after two weeks ( P 〈 0.05 ). 7 patients had complications and the symptoms disappeared after corresponding treatment. Conclusion : PTCD for hilar malignant obstructive jaundice could relieve symptoms caused by jaundice. Patients had good tolerance. PTCD may provide opportunities for subsequent antitumor therapy.
出处
《河南医学研究》
CAS
2014年第3期21-22,共2页
Henan Medical Research
关键词
梗阻性黄疸
经皮肝穿刺胆道引流
肝门部恶性肿瘤
obstruction jaundice
percutaneous transhepatic cholangial drainage
hilar tumors